Skip to content
  • pharma

Carbomer copolymer type a (allyl pentaerythritol crosslinked)

CAS 145687-02-1

Also registered as 1 other CAS number

9007-20-9

Concern score

Not assessed — no hazard data yet.

Carbomer copolymer type a (allyl pentaerythritol crosslinked) in plain language

What it is

Also known as Carbomer copolymer type a · Pemulen TR-2

What it does

We don't have a plain-language description for Carbomer copolymer type a (allyl pentaerythritol crosslinked) yet.

Is it a concern?
We haven't assessed a concern score for this ingredient yet.

Regulation

No restrictions found. Carbomer copolymer type a (allyl pentaerythritol crosslinked) appears in these published regulatory listings.

  • Inactive ingredient in US drugs
  • In marketed US drugs
  • USFDAinactive ingredient database3 entries — 2 administration routes
    • Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.05 %w/vSource →
    • Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 25 mgSource →
    • Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 21 mgSource →
  • USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 2 drug products and 2 package presentations.
    • FDA NDC lists this ingredient in 2 drug products and 2 package presentations.Source →
  • USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as polymer.
    • openFDA substance registry classifies this ingredient as polymer.Source →

Evidence & sources

No graded research studies for Carbomer copolymer type a (allyl pentaerythritol crosslinked) yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

4 data sources

Where this comes from

  • FDA Inactive Ingredient Database

    regulatory · updated 2026-01-09

    Open →
  • FDA National Drug Code Directory

    regulatory · updated 2028-03-09

    Open →
  • FDA GSRS UNII

    registry · updated 2026-02-26

    Open →
  • openFDA Substance

    registry · updated 2026-05-24

    Open →
Reference links (1)

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.

Where it has been recorded

How often FDA National Drug Code directory has listed Carbomer copolymer type a (allyl pentaerythritol crosslinked) in a product composition. These are source records, not Greenveil catalog products.

Source records

2

See products using Carbomer copolymer type a (allyl pentaerythritol crosslinked) →

Catalog

Found in these products

Their ingredient lists include Carbomer copolymer type a (allyl pentaerythritol crosslinked); each product's own rating depends on its whole formula, so it is shown on the product page, not here.